Jump to content

Examine individual changes

This page allows you to examine the variables generated by the Edit Filter for an individual change.

Variables generated for this change

VariableValue
Edit count of the user (user_editcount)
3
Name of the user account (user_name)
'Jldanon'
Age of the user account (user_age)
88650360
Groups (including implicit) the user is in (user_groups)
[ 0 => '*', 1 => 'user' ]
Global groups that the user is in (global_user_groups)
[]
Whether or not a user is editing through the mobile interface (user_mobile)
false
Page ID (page_id)
4812286
Page namespace (page_namespace)
0
Page title without namespace (page_title)
'Omnicare'
Full page title (page_prefixedtitle)
'Omnicare'
Last ten users to contribute to the page (page_recent_contributors)
[ 0 => 'Jldanon', 1 => 'Stevietheman', 2 => '129.137.165.255', 3 => 'Physicsmathftw', 4 => '63.146.162.121', 5 => 'K6ka', 6 => 'BattyBot', 7 => '71.124.255.97', 8 => 'Patapsco913', 9 => 'Wouterstomp' ]
Action (action)
'edit'
Edit summary/reason (summary)
''
Whether or not the edit is marked as minor (no longer in use) (minor_edit)
false
Old page wikitext, before the edit (old_wikitext)
'{{Infobox company | name = Omnicare, Inc. | logo = [[File:Omnicare Logo.JPG|120px]] | industry = [[Pharmaceuticals]] | location_city = [[Cincinnati, Ohio]] | location_country = USA | homepage = http://www.omnicare.com/ | type = [[Public company|Public]] | traded_as = {{NYSE|OCR}} | key_people = {{unbulleted list | [[John L. Workman]] ([[Chief executive officer|CEO]]) | [[Nitin Sahney]] ([[President]] and [[Chief Operating Officer|COO]]; CEO-elect)<ref>{{cite web |url=http://www.bizjournals.com/louisville/news/2014/03/25/omnicare-gets-its-fourth-ceo-in-four-years.html |title=Omnicare gets its fourth CEO in four years |publisher=Louisville Business First |author=David A. Mann |date=25 Mar 2014 |accessdate=24 Jun 2014}}</ref> | [[Rocky Kraft]] ([[Chief Financial Officer|CFO]])}} }} [[File:Omnicare NYSE 2011 Shankbone.jpg|thumb|The [[New York Stock Exchange]] building on September 1, 2011 with an Omnicare banner marking the 30th anniversary of the company's public listing.]] '''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare functions primarily as a provider of [[pharmaceutical]]s, related consulting and data management services. As of December 31, 2009 the company provided its pharmacy services to skilled nursing, assisted living, and other healthcare facilities comprising approximately 1.4 million beds in 47 [[U.S. state]]s, the [[District of Columbia]] and [[Canada]]. Omnicare's CEO is Dominic J. Rosso In 2012, the Federal Trade Commission (FTC) sued Omnicare to block its [[hostile takeover]] of its rival [[PharMerica]] under federal [[anti-trust law]]. The FTC alleged that the acquisition would boost drug costs and inflate Medicare expenditures by consolidating the industry and reducing price competition.<ref name="FTC Blocks Deal">{{cite web|title=FTC Sues to Block Omnicare's Bid to Buy Rival Pharmacy Provider PharMerica; Deal Would Lead to Higher Costs for Medicare Patients and Taxpayers, Agency Alleges|url=http://www.ftc.gov/opa/2012/01/omnicare.shtm|publisher=Federal Trade Commission|accessdate=12 September 2013}}</ref> PharMerica owned 97 long-term-care pharmacies, while Omnicare owned approximately 200. The merger would have given Omnicare a 57% marketshare versus two percent for its nearest, non-PharMerica rival.<ref name="FTC blocks merger">{{cite web|title=FTC blocks Omnicare acquisition of PharMerica|url=http://drugtopics.modernmedicine.com/drug-topics/news/ftc-blocks-omnicare-acquisition-pharmerica|publisher=Drug Topics|accessdate=12 September 2013}}</ref> Because of the FTC opposition, the takeover was terminated. ==Whistleblower lawsuits== In November 2009, Omnicare paid $98 million to the federal government to settle five "[[qui tam]]" ([[whistleblower]]) lawsuits and government charges that the company had paid or solicited a variety of [[Kickback (bribery)|kickbacks]].<ref>{{cite news|author=[[United States Department of Justice|Department of Justice]]|title=Nation's largest nursing home pharmacy and drug manufacturer to pay $112 million to settle false claims act cases|date=November 3, 2009|url=http://www.justice.gov/opa/pr/2009/November/09-civ-1186.html}}</ref> The company admitted no wrongdoing.<ref>{{cite news|author=Hilzenrath, David S.|date=January 16, 2010|title=Justice suit accuses Johnson & Johnson of paying kickbacks|url=http://www.washingtonpost.com/wp-dyn/content/article/2010/01/15/AR2010011503903.html|publisher=The Washington Post|accessdate=January 17, 2010}}</ref> The charges included allegations that Omicare solicited and received kickbacks from a pharmaceutical manufacturer [[Johnson & Johnson]], in exchange for agreeing to recommend that physicians prescribe Risperdal, a Johnson & Johnson antipsychotic drug, to nursing home patients. Starting in 2006, healthcare entrepreneur [[Adam B. Resnick]] sued Omnicare, a major supplier of drugs to [[nursing homes]], under the [[False Claims Act]], as well as the parties to the company's illegal kickback schemes. Omnicare allegedly paid kickbacks to nursing home operators in order to secure business, which constitutes [[Medicare fraud|Medicare]] and [[Medicaid fraud]]. Omnicare allegedly had paid $50 million to the owners (Leonard Grunstein and [[Rubin Schron]]) of the Mariner Health Care Inc. and SavaSeniorCare Administrative Services LLC nursing home chains in exchange for the right to continue providing pharmacy services to the nursing homes.<ref>{{cite news|author=U.S. Department of Justice|title=Complaint of the United States in the District Court of Massachusetts CA No. 06-10149 RGS| date=March 4, 2009|url=http://www.phillipsandcohen.com/CM/NewsSettlements/United%20States%20v%20%20Omnicare%20Mariner%20et%20al%20%20complaint.pdf}}</ref> In 2010, Omnicare settled Resnick's False Claims Act suit that had been taken up by the [[U.S. Department of Justice]] by paying $19.8 million to the federal government, while Mariner and SavaSeniorCare settled for $14 million.<ref>{{cite web|last=Ameet|first=Sachdev|title=Scheme's victims Scheme's victims seeking restitution FDIC could get most of payment; FDIC could get most of payment|url=http://articles.chicagotribune.com/2010-02-11/news/1002100576_1_fdic-restitution-bank-fraud|publisher=Chicago Tribune|accessdate=12 September 2013}}</ref><ref>{{cite web|title=Prominent New York City Real Estate Investor, Attorney and Atlanta Nursing Home Chains Pay $14 Million to Settle Whistleblower Kickback Case|url=http://www.prnewswire.com/news-releases/prominent-new-york-city-real-estate-investor-attorney-and-atlanta-nursing-home-chains-pay-14-million-to-settle-whistleblower-kickback-case-85506647.html|publisher=PR Newswire|accessdate=12 September 2013}}</ref> A second whistleblower lawsuit filed against Omnicare it by Resnick and Total Pharmacy Services V.P. Maureen Nehls related to kickbacks that were part of its 2004 acquisition of Total Pharmacy Services was settled for $17.2 million by Omnicare and $5 million by the Total Pharmacy owners.<ref>{{cite news|last=Monk|first=Dan|title=Omnicare settles whistleblower case in Illnois|url=http://www.wcpo.com/money/local-business-news/omnicare-settles-whistleblower-case-in-illnois|accessdate=12 September 2013|newspaper=Scripps Media|date=16 July 2013}}</ref><ref>{{cite news|last=Jackson|first=David & Gary Marx|title=Nursing home execs agree to pay $5 million to settle suit|url=http://articles.chicagotribune.com/2013-08-06/news/ct-met-esformes-settlement-20130807_1_maureen-nehls-morris-esformes-total-pharmacy|accessdate=12 September 2013|newspaper=Chicago Tribune|date=6 August 2013}}</ref> ==Notes== {{reflist}} ==External links== * [http://www.law.ufl.edu/faculty/pdf/9-4-03hanew.pdf Omnicare v. NCS Healthcare] - Major case involving anti-takeover provisions. [[Category:Companies listed on the New York Stock Exchange]] [[Category:Health care companies of the United States]] [[Category:Pharmacy Benefit Management companies based in the United States]]'
New page wikitext, after the edit (new_wikitext)
'{{Infobox company | name = Omnicare, Inc. | logo = [[File:Omnicare Logo.JPG|120px]] | industry = [[Pharmaceuticals]] | location_city = [[Cincinnati, Ohio]] | location_country = USA | homepage = http://www.omnicare.com/ | type = [[Public company|Public]] | traded_as = {{NYSE|OCR}} | key_people = {{unbulleted list | [[John L. Workman]] ([[Chief executive officer|CEO]]) | [[Nitin Sahney]] ([[President]] and [[Chief Operating Officer|COO]]; CEO-elect)<ref>{{cite web |url=http://www.bizjournals.com/louisville/news/2014/03/25/omnicare-gets-its-fourth-ceo-in-four-years.html |title=Omnicare gets its fourth CEO in four years |publisher=Louisville Business First |author=David A. Mann |date=25 Mar 2014 |accessdate=24 Jun 2014}}</ref> | [[Rocky Kraft]] ([[Chief Financial Officer|CFO]])}} }} [[File:Omnicare NYSE 2011 Shankbone.jpg|thumb|The [[New York Stock Exchange]] building on September 1, 2011 with an Omnicare banner marking the 30th anniversary of the company's public listing.]] '''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group. ==Whistleblower lawsuits== In November 2009, Omnicare paid $98 million to the federal government to settle five "[[qui tam]]" ([[whistleblower]]) lawsuits and government charges that the company had paid or solicited a variety of [[Kickback (bribery)|kickbacks]].<ref>{{cite news|author=[[United States Department of Justice|Department of Justice]]|title=Nation's largest nursing home pharmacy and drug manufacturer to pay $112 million to settle false claims act cases|date=November 3, 2009|url=http://www.justice.gov/opa/pr/2009/November/09-civ-1186.html}}</ref> The company admitted no wrongdoing.<ref>{{cite news|author=Hilzenrath, David S.|date=January 16, 2010|title=Justice suit accuses Johnson & Johnson of paying kickbacks|url=http://www.washingtonpost.com/wp-dyn/content/article/2010/01/15/AR2010011503903.html|publisher=The Washington Post|accessdate=January 17, 2010}}</ref> The charges included allegations that Omicare solicited and received kickbacks from a pharmaceutical manufacturer [[Johnson & Johnson]], in exchange for agreeing to recommend that physicians prescribe Risperdal, a Johnson & Johnson antipsychotic drug, to nursing home patients. Starting in 2006, healthcare entrepreneur [[Adam B. Resnick]] sued Omnicare, a major supplier of drugs to [[nursing homes]], under the [[False Claims Act]], as well as the parties to the company's illegal kickback schemes. Omnicare allegedly paid kickbacks to nursing home operators in order to secure business, which constitutes [[Medicare fraud|Medicare]] and [[Medicaid fraud]]. Omnicare allegedly had paid $50 million to the owners (Leonard Grunstein and [[Rubin Schron]]) of the Mariner Health Care Inc. and SavaSeniorCare Administrative Services LLC nursing home chains in exchange for the right to continue providing pharmacy services to the nursing homes.<ref>{{cite news|author=U.S. Department of Justice|title=Complaint of the United States in the District Court of Massachusetts CA No. 06-10149 RGS| date=March 4, 2009|url=http://www.phillipsandcohen.com/CM/NewsSettlements/United%20States%20v%20%20Omnicare%20Mariner%20et%20al%20%20complaint.pdf}}</ref> In 2010, Omnicare settled Resnick's False Claims Act suit that had been taken up by the [[U.S. Department of Justice]] by paying $19.8 million to the federal government, while Mariner and SavaSeniorCare settled for $14 million.<ref>{{cite web|last=Ameet|first=Sachdev|title=Scheme's victims Scheme's victims seeking restitution FDIC could get most of payment; FDIC could get most of payment|url=http://articles.chicagotribune.com/2010-02-11/news/1002100576_1_fdic-restitution-bank-fraud|publisher=Chicago Tribune|accessdate=12 September 2013}}</ref><ref>{{cite web|title=Prominent New York City Real Estate Investor, Attorney and Atlanta Nursing Home Chains Pay $14 Million to Settle Whistleblower Kickback Case|url=http://www.prnewswire.com/news-releases/prominent-new-york-city-real-estate-investor-attorney-and-atlanta-nursing-home-chains-pay-14-million-to-settle-whistleblower-kickback-case-85506647.html|publisher=PR Newswire|accessdate=12 September 2013}}</ref> A second whistleblower lawsuit filed against Omnicare it by Resnick and Total Pharmacy Services V.P. Maureen Nehls related to kickbacks that were part of its 2004 acquisition of Total Pharmacy Services was settled for $17.2 million by Omnicare and $5 million by the Total Pharmacy owners.<ref>{{cite news|last=Monk|first=Dan|title=Omnicare settles whistleblower case in Illnois|url=http://www.wcpo.com/money/local-business-news/omnicare-settles-whistleblower-case-in-illnois|accessdate=12 September 2013|newspaper=Scripps Media|date=16 July 2013}}</ref><ref>{{cite news|last=Jackson|first=David & Gary Marx|title=Nursing home execs agree to pay $5 million to settle suit|url=http://articles.chicagotribune.com/2013-08-06/news/ct-met-esformes-settlement-20130807_1_maureen-nehls-morris-esformes-total-pharmacy|accessdate=12 September 2013|newspaper=Chicago Tribune|date=6 August 2013}}</ref> ==Notes== {{reflist}} ==External links== * [http://www.law.ufl.edu/faculty/pdf/9-4-03hanew.pdf Omnicare v. NCS Healthcare] - Major case involving anti-takeover provisions. [[Category:Companies listed on the New York Stock Exchange]] [[Category:Health care companies of the United States]] [[Category:Pharmacy Benefit Management companies based in the United States]]'
Unified diff of changes made by edit (edit_diff)
'@@ -14,9 +14,8 @@ }} [[File:Omnicare NYSE 2011 Shankbone.jpg|thumb|The [[New York Stock Exchange]] building on September 1, 2011 with an Omnicare banner marking the 30th anniversary of the company's public listing.]] -'''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare functions primarily as a provider of [[pharmaceutical]]s, related consulting and data management services. As of December 31, 2009 the company provided its pharmacy services to skilled nursing, assisted living, and other healthcare facilities comprising approximately 1.4 million beds in 47 [[U.S. state]]s, the [[District of Columbia]] and [[Canada]]. Omnicare's CEO is Dominic J. Rosso +'''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group. -In 2012, the Federal Trade Commission (FTC) sued Omnicare to block its [[hostile takeover]] of its rival [[PharMerica]] under federal [[anti-trust law]]. The FTC alleged that the acquisition would boost drug costs and inflate Medicare expenditures by consolidating the industry and reducing price competition.<ref name="FTC Blocks Deal">{{cite web|title=FTC Sues to Block Omnicare's Bid to Buy Rival Pharmacy Provider PharMerica; Deal Would Lead to Higher Costs for Medicare Patients and Taxpayers, Agency Alleges|url=http://www.ftc.gov/opa/2012/01/omnicare.shtm|publisher=Federal Trade Commission|accessdate=12 September 2013}}</ref> PharMerica owned 97 long-term-care pharmacies, while Omnicare owned approximately 200. The merger would have given Omnicare a 57% marketshare versus two percent for its nearest, non-PharMerica rival.<ref name="FTC blocks merger">{{cite web|title=FTC blocks Omnicare acquisition of PharMerica|url=http://drugtopics.modernmedicine.com/drug-topics/news/ftc-blocks-omnicare-acquisition-pharmerica|publisher=Drug Topics|accessdate=12 September 2013}}</ref> Because of the FTC opposition, the takeover was terminated. ==Whistleblower lawsuits== In November 2009, Omnicare paid $98 million to the federal government to settle five "[[qui tam]]" ([[whistleblower]]) lawsuits and government charges that the company had paid or solicited a variety of [[Kickback (bribery)|kickbacks]].<ref>{{cite news|author=[[United States Department of Justice|Department of Justice]]|title=Nation's largest nursing home pharmacy and drug manufacturer to pay $112 million to settle false claims act cases|date=November 3, 2009|url=http://www.justice.gov/opa/pr/2009/November/09-civ-1186.html}}</ref> The company admitted no wrongdoing.<ref>{{cite news|author=Hilzenrath, David S.|date=January 16, 2010|title=Justice suit accuses Johnson & Johnson of paying kickbacks|url=http://www.washingtonpost.com/wp-dyn/content/article/2010/01/15/AR2010011503903.html|publisher=The Washington Post|accessdate=January 17, 2010}}</ref> The charges included allegations that Omicare solicited and received kickbacks from a pharmaceutical manufacturer [[Johnson & Johnson]], in exchange for agreeing to recommend that physicians prescribe Risperdal, a Johnson & Johnson antipsychotic drug, to nursing home patients. '
New page size (new_size)
6104
Old page size (old_size)
7018
Size change in edit (edit_delta)
-914
Lines added in edit (added_lines)
[ 0 => ''''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group.' ]
Lines removed in edit (removed_lines)
[ 0 => ''''Omnicare''' is a [[Fortune 500]] company based in [[Cincinnati, Ohio]]. Omnicare functions primarily as a provider of [[pharmaceutical]]s, related consulting and data management services. As of December 31, 2009 the company provided its pharmacy services to skilled nursing, assisted living, and other healthcare facilities comprising approximately 1.4 million beds in 47 [[U.S. state]]s, the [[District of Columbia]] and [[Canada]]. Omnicare's CEO is Dominic J. Rosso', 1 => 'In 2012, the Federal Trade Commission (FTC) sued Omnicare to block its [[hostile takeover]] of its rival [[PharMerica]] under federal [[anti-trust law]]. The FTC alleged that the acquisition would boost drug costs and inflate Medicare expenditures by consolidating the industry and reducing price competition.<ref name="FTC Blocks Deal">{{cite web|title=FTC Sues to Block Omnicare's Bid to Buy Rival Pharmacy Provider PharMerica; Deal Would Lead to Higher Costs for Medicare Patients and Taxpayers, Agency Alleges|url=http://www.ftc.gov/opa/2012/01/omnicare.shtm|publisher=Federal Trade Commission|accessdate=12 September 2013}}</ref> PharMerica owned 97 long-term-care pharmacies, while Omnicare owned approximately 200. The merger would have given Omnicare a 57% marketshare versus two percent for its nearest, non-PharMerica rival.<ref name="FTC blocks merger">{{cite web|title=FTC blocks Omnicare acquisition of PharMerica|url=http://drugtopics.modernmedicine.com/drug-topics/news/ftc-blocks-omnicare-acquisition-pharmerica|publisher=Drug Topics|accessdate=12 September 2013}}</ref> Because of the FTC opposition, the takeover was terminated.' ]
Whether or not the change was made through a Tor exit node (tor_exit_node)
0
Unix timestamp of change (timestamp)
1423776517